Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia

Mech Ageing Dev. 2020 Dec:192:111361. doi: 10.1016/j.mad.2020.111361. Epub 2020 Sep 28.

Abstract

The use of animal models is fundamental to furthering our understanding of human disease mechanisms, as well as identifying potential therapeutic targets. Diseases of ageing often involve multiple body systems; however, multi-systemic features are not fully recapitulated in the many of the animal models available. Therefore, combining pre-clinical models to better reflect the multimorbidities observed at the clinical level is critical. This review will highlight some of the key pre-clinical experimental models associated with cardiovascular (atherosclerosis, coronary heart disease), cerebrovascular (stroke, vascular dementia), metabolic (obesity, type-2 diabetes mellitus) and neurological (amyotrophic lateral sclerosis, frontotemporal dementia, Parkinson's, epilepsy) diseases, and whether these models encompass known multimorbidities. In addition to this, we discuss established pre-clinical models that combine two or more conditions, within the context of dementia.

Keywords: Animal models; Cardiovascular; Cerebrovascular; Multimorbidity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging / physiology*
  • Animals
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / metabolism
  • Cardiovascular Diseases* / physiopathology
  • Disease Models, Animal*
  • Drug Evaluation, Preclinical / methods
  • Humans
  • Metabolic Diseases* / drug therapy
  • Metabolic Diseases* / metabolism
  • Metabolic Diseases* / physiopathology
  • Multimorbidity
  • Neurodegenerative Diseases* / drug therapy
  • Neurodegenerative Diseases* / metabolism
  • Neurodegenerative Diseases* / physiopathology